Bitcoin Depot Announces Strategic Investment from Sopris Capital
April 25, 2024 08:05 ET
|
Bitcoin Depot Inc.
ATLANTA, April 25, 2024 (GLOBE NEWSWIRE) -- Bitcoin Depot (“Bitcoin Depot” or the “Company”) (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced a...
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
April 25, 2024 08:01 ET
|
Standard BioTools Inc.
Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on...
Lakeland Financial Reports First Quarter Net Income of $23.4 Million and 5% Annualized Average Loan Growth
April 25, 2024 08:00 ET
|
Lake City Bank
WARSAW, Ind., April 25, 2024 (GLOBE NEWSWIRE) -- Lakeland Financial Corporation (Nasdaq Global Select/LKFN), parent company of Lake City Bank, today reported net income of $23.4 million for the...
First Merchants Corporation Announces First Quarter 2024 Earnings Per Share
April 25, 2024 08:00 ET
|
First Merchants Corporation
MUNCIE, Ind., April 25, 2024 (GLOBE NEWSWIRE) -- First Merchants Corporation (NASDAQ - FRME) First Quarter 2024 Highlights: Net income available to common stockholders was $47.5 million and...
Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024
April 25, 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., April 25, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the Treatment of Patients with Metastatic or Locally Advanced Biliary Tract Tumors That Have Been Previously Treated
April 25, 2024 08:00 ET
|
Compass Therapeutics
CTX-009, the Company’s bispecific DLL4/VEGF-A antibody, in combination with paclitaxel, has shown promising clinical responses in patients with advanced biliary tract cancer (BTC) in its Phase 2 study...
Genasys Inc. Schedules Fiscal Second Quarter 2024 Financial Results and Conference Call for May 14, 2024
April 25, 2024 08:00 ET
|
Genasys Inc.
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Genasys Inc. (NASDAQ: GNSS), the global leader in protective communications, today announced plans to release financial results for its fiscal second...
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
April 25, 2024 08:00 ET
|
MediWound Ltd.
Oral presentations include additional comparative data between EscharEx® and SANTYL®, and new analyses show strong correlation between wound bed preparation and wound healing Analyses validate the...
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
April 25, 2024 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
April 25, 2024 08:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet...